Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Classificação em ações #33273
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Preço da ação
$5.47
Última sincronização: 2026-08-14
Valor de mercado
$7.99M
Variação (1 dia)
6.21%
Variação (1 ano)
7.47%
País
US
Negociar CNS Pharmaceuticals, Inc. (CNSP)

Categoria

Histórico de preços das ações de CNS Pharmaceuticals, Inc. (CNSP)
Preço de fecho mais alto: $5.27 em 2026-08-01

Preço de fecho mais baixo: $3.79M em 2019-11-01
Histórico de preços das ações da CNS Pharmaceuticals, Inc. de 2019 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -16.52%
2025 -89.84%
2024 -99.87%
2023 -34.43%
2022 -90.86%
2021 -58.90%
2020 -43.49%
2019 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$737.68 7.34%
CH
$1.07K -6.40%
KR
$254.55 12.96%
BE